Non-Invasive Physiological Stratification of Echocardiographic Right Ventricular Involvement in Suspected Pulmonary Hypertension: The NIRV Score and Its TAPSE/PASP-Defined Binary Classification

Background/Objectives: In suspected pulmonary hypertension (PH), functional limitation may reflect right ventricular (RV) involvement and non-RV comorbidity. We developed the Non-Invasive Right Ventricular (NIRV) score, integrating RV–pulmonary arterial coupling and myocardial stress, to identify objective RV disease and assess prognostic information beyond World Health Organization functional class (WHO-FC). Methods: This single-centre retrospective cohort included consecutive adults evaluated for suspected PH. NIRV assigns 2 points for tricuspid annular plane systolic excursion to pulmonary artery systolic pressure ratio (TAPSE/PASP) ≤0.31 mm/mmHg and 1 point for N-terminal pro–B-type natriuretic peptide (NT-proBNP) ≥1400 pg/mL, yielding a 0–3 score. Thus, binary NIRV classification (0–1 vs. 2–3) depends exclusively on TAPSE/PASP ≤ 0.31 mm/mmHg. Objective RV disease required abnormalities in at least two of three prespecified echocardiographic domains and was defined independently of WHO-FC, TAPSE/PASP, NT-proBNP, and NIRV-derived classifications. Results: Of 490 patients, 379 had an available NIRV score, and objective RV disease was evaluable in 379 patients, of whom 158 (41.7%) met the echocardiographic RV involvement criteria. Among 358 patients with valid WHO-FC data, TAPSE/PASP-defined classification showed higher sensitivity (77.5% vs. 35.8%) but lower specificity (61.8% vs. 75.8%) than WHO-FC III–IV. In the 379-patient cohort, the AUC increased only marginally when continuous NT-proBNP was added to TAPSE/PASP (0.777 to 0.782). WHO-low/NIRV-high discordance occurred in 126/361 (34.9%); 71/126 with outcome data (56.3%) had objective RV disease. The date-complete survival cohort included 379 patients (140 deaths), with a median follow-up of 727 days. In the clinically adjusted Cox model (n = 354; 128 deaths), NIRV 3 was associated with higher mortality hazard than NIRV 0 (HR, 2.59; 95% CI, 1.46–4.59), although the association across score categories was nonmonotonic. Conclusions: The TAPSE/PASP-defined binary NIRV classification was associated with the study-defined echocardiographic RV involvement phenotype, whereas the full 0–3 score retained information from both physiological components. Categorical NIRV was associated with all-cause mortality in exploratory Cox analyses, without a monotonic mortality gradient. Prospective external validation is required before use.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-18
DOI
https://doi.org/10.3390/jcm15229039
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Non-Invasive Physiological Stratification of Echocardiographic Right Ventricular Involvement in Suspected Pulmonary Hypertension: The NIRV Score and Its TAPSE/PASP-Defined Binary Classification

Juan Luis Rodríguez Hermosa, Carmen Olmos, Iman Esmaili, Myriam Calle Rubio et al.
1 links
Journal of Clinical Medicine
Pulmonary Hypertension Research and Treatments
article

Non-Invasive Physiological Stratification of Echocardiographic Right Ventricular Involvement in Suspected Pulmonary Hypertension: The NIRV Score and Its TAPSE/PASP-Defined Binary Classification

Juan Luis Rodríguez Hermosa, Carmen Olmos, Iman Esmaili, Myriam Calle Rubio, Angel L. Cogolludo, José Alberto de Agustín, Soha Esmaili, Francisco Pérez‐Vizcaíno, Lucia Gómez Martín-Caro, Celia Sánchez Sampedro, Alejandro Rodríguez, Fernando Octavio Cardenas
article en

Abstract

Background/Objectives: In suspected pulmonary hypertension (PH), functional limitation may reflect right ventricular (RV) involvement and non-RV comorbidity. We developed the Non-Invasive Right Ventricular (NIRV) score, integrating RV–pulmonary arterial coupling and myocardial stress, to identify objective RV disease and assess prognostic information beyond World Health Organization functional class (WHO-FC). Methods: This single-centre retrospective cohort included consecutive adults evaluated for suspected PH. NIRV assigns 2 points for tricuspid annular plane systolic excursion to pulmonary artery systolic pressure ratio (TAPSE/PASP) ≤0.31 mm/mmHg and 1 point for N-terminal pro–B-type natriuretic peptide (NT-proBNP) ≥1400 pg/mL, yielding a 0–3 score. Thus, binary NIRV classification (0–1 vs. 2–3) depends exclusively on TAPSE/PASP ≤ 0.31 mm/mmHg. Objective RV disease required abnormalities in at least two of three prespecified echocardiographic domains and was defined independently of WHO-FC, TAPSE/PASP, NT-proBNP, and NIRV-derived classifications. Results: Of 490 patients, 379 had an available NIRV score, and objective RV disease was evaluable in 379 patients, of whom 158 (41.7%) met the echocardiographic RV involvement criteria. Among 358 patients with valid WHO-FC data, TAPSE/PASP-defined classification showed higher sensitivity (77.5% vs. 35.8%) but lower specificity (61.8% vs. 75.8%) than WHO-FC III–IV. In the 379-patient cohort, the AUC increased only marginally when continuous NT-proBNP was added to TAPSE/PASP (0.777 to 0.782). WHO-low/NIRV-high discordance occurred in 126/361 (34.9%); 71/126 with outcome data (56.3%) had objective RV disease. The date-complete survival cohort included 379 patients (140 deaths), with a median follow-up of 727 days. In the clinically adjusted Cox model (n = 354; 128 deaths), NIRV 3 was associated with higher mortality hazard than NIRV 0 (HR, 2.59; 95% CI, 1.46–4.59), although the association across score categories was nonmonotonic. Conclusions: The TAPSE/PASP-defined binary NIRV classification was associated with the study-defined echocardiographic RV involvement phenotype, whereas the full 0–3 score retained information from both physiological components. Categorical NIRV was associated with all-cause mortality in exploratory Cox analyses, without a monotonic mortality gradient. Prospective external validation is required before use.

Journal of Clinical MedicineVol. 15(22)
Universidad Complutense de Madrid (ES), Hospital Clínico San Carlos (ES), Universidad Nebrija (ES), Hospital La Luz (ES), Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES), Hospital Universitario Quirónsalud Madrid (ES), IDCQ Hospitales y Sanidad, S.L.U. (ES), Universidad Europea de Madrid (ES)
Good health and well-being
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon